Table of Content

1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Biopharmaceutical Third-party Logistics Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Supply Chain (Cold Chain, Non-cold Chain)
5.2.2. By Service Type (Transportation, Warehousing & Storage, Other)
5.2.3. By Region
5.2.4. By Company (2022)
5.3. Market Map
6. North America Biopharmaceutical Third-party Logistics Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Supply Chain
6.2.2. By Service Type
6.2.3. By Country
6.3. North America: Country Analysis
6.3.1. United States Biopharmaceutical Third-party Logistics Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Supply Chain
6.3.1.2.2. By Service Type
6.3.2. Canada Biopharmaceutical Third-party Logistics Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Supply Chain
6.3.2.2.2. By Service Type
6.3.3. Mexico Biopharmaceutical Third-party Logistics Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Supply Chain
6.3.3.2.2. By Service Type
7. Europe Biopharmaceutical Third-party Logistics Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Supply Chain
7.2.2. By Service Type
7.3. Europe: Country Analysis
7.3.1. Germany Biopharmaceutical Third-party Logistics Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Supply Chain
7.3.1.2.2. By Service Type
7.3.2. United Kingdom Biopharmaceutical Third-party Logistics Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Supply Chain
7.3.2.2.2. By Service Type
7.3.3. Italy Biopharmaceutical Third-party Logistics Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecasty
7.3.3.2.1. By Supply Chain
7.3.3.2.2. By Service Type
7.3.4. France Biopharmaceutical Third-party Logistics Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Supply Chain
7.3.4.2.2. By Service Type
7.3.5. Spain Biopharmaceutical Third-party Logistics Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Supply Chain
7.3.5.2.2. By Service Type
8. Asia-Pacific Biopharmaceutical Third-party Logistics Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Supply Chain
8.2.2. By Service Type
8.3. Asia-Pacific: Country Analysis
8.3.1. China Biopharmaceutical Third-party Logistics Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Supply Chain
8.3.1.2.2. By Service Type
8.3.2. India Biopharmaceutical Third-party Logistics Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Supply Chain
8.3.2.2.2. By Service Type
8.3.3. Japan Biopharmaceutical Third-party Logistics Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Supply Chain
8.3.3.2.2. By Service Type
8.3.4. South Korea Biopharmaceutical Third-party Logistics Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Supply Chain
8.3.4.2.2. By Service Type
8.3.5. Australia Biopharmaceutical Third-party Logistics Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Supply Chain
8.3.5.2.2. By Service Type
9. South America Biopharmaceutical Third-party Logistics Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Supply Chain
9.2.2. By Service Type
9.3. South America: Country Analysis
9.3.1. Brazil Biopharmaceutical Third-party Logistics Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Supply Chain
9.3.1.2.2. By Service Type
9.3.2. Argentina Biopharmaceutical Third-party Logistics Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Supply Chain
9.3.2.2.2. By Service Type
9.3.3. Colombia Biopharmaceutical Third-party Logistics Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Supply Chain
9.3.3.2.2. By Service Type
10. Middle East and Africa Biopharmaceutical Third-party Logistics Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Supply Chain
10.2.2. By Service Type
10.3. MEA: Country Analysis
10.3.1. South Africa Biopharmaceutical Third-party Logistics Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Supply Chain
10.3.1.2.2. By Service Type
10.3.2. Saudi Arabia Biopharmaceutical Third-party Logistics Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Supply Chain
10.3.2.2.2. By Service Type
10.3.3. UAE Biopharmaceutical Third-party Logistics Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Supply Chain
10.3.3.2.2. By Service Type
11. Market Dynamics
11.1. Drivers & Challenges
12. Market Trends & Developments
12.1. Recent Developments
12.2. Product Launches
12.3. Mergers & Acquisitions
13. Global Biopharmaceutical Third-party Logistics Market: SWOT Analysis
14. Competitive Landscape
14.1. DHL International GmbH.
14.2. SF Express Co.
14.3. United Parcel Service of America, Inc.
14.4. AmerisourceBergen Corporation
14.5. DB Schenker
14.6. Kuehne and Nagel AG
14.7. Kerry Logistics Network Ltd.
14.8. Agility Co.
15. Strategic Recommendations
16. About Us & Disclaimer